Gene Name,Gene Symbol,Entrez Gene ID,Classification in Possemato et al.,Classification used in this study,No. of datasets,*Significantly altered in Proteomics,Corr. with progression markers,Predicts OS (Log-ranked P-value),"Tumour size [S vs L, P<0.05]",**Previous study in HCC?,Note from previous HCC study,*Link to reference,Link to reference
"pyruvate dehydrogenase lipoamide kinase isozyme 4, mitochondrial",PDK4,5166,-,Glycolysis,7,-,Yes,"0,0177","0,0363477",-,Unclear,https://www.ncbi.nlm.nih.gov/pubmed/?term=PDK4+hcc,
"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",ABCC9,10060,ABC Transporter,ABC Transporter,6,-,Yes,not sig.,not sig.,-,-,-,
"ATP-binding cassette, sub-family D (ALD), member 3",ABCD3,5825,ABC Transporter,ABC Transporter,6,Up,Yes,not sig.,"0,0194831",-,-,-,
"ATP-binding cassette, sub-family A (ABC1), member 8",ABCA8,10351,ABC Transporter,ABC Transporter,7,-,Yes,"Showed trend, P>0.1","0,0407963",-,-,-,
"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",ABCC6,368,ABC Transporter,ABC Transporter,8,-,Yes,"0,0106","0,000180878",-,-,-,
"ATP-binding cassette, sub-family A (ABC1), member 6",ABCA6,23460,ABC Transporter,ABC Transporter,7,-,Yes,"0,0015","0,00840123",-,-,-,
serine dehydratase,SDS,10993,Amino Acid,Amino Acid*,7,-,Yes,not sig.,not sig.,-,"No data with HCC but liver cancer, seems to be mostly rat hepatomas in the 90s",-,
aspartoacylase (Canavan disease),ASPA,443,Amino Acid,Amino Acid*,7,-,Yes,not sig.,"0,061",-,-,-,
lens protein with glutamine synthetase domain ,LGSN,51557,Amino Acid,Amino Acid*,6,-,Yes,not sig.,"0,015",-,-,-,
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha,PCBD1,5092,Amino Acid,Amino Acid*,8,Down,Yes,not sig.,not sig.,-,none in other cancers,-,
threonine synthase-like 1 (S. cerevisiae),THNSL1,79896,Amino Acid,Amino Acid*,6,Down,Yes,"0,0256",not sig.,-,none in any cancer,-,
acireductone dioxygenase 1,ADI1,55256,Amino Acid,Amino Acid*,6,Down,Yes,"0,0029","0,020",-,-,-,
D-amino-acid oxidase,DAO,1610,Amino Acid,Amino Acid*,6,Down,Yes,"0,0038","0,050","Sun and Cederbaum, 1980",Slightly lowered in HCC,http://www.ncbi.nlm.nih.gov/pubmed/6893680 ,
glutamic-pyruvate transaminase (alanine aminotransferase),GPT,2875,Amino Acid,Amino Acid*,8,Down,Yes,not sig.,not sig.,-,-,-,
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),GCAT,23464,Amino Acid,Amino Acid*,7,Down,Yes,not sig.,not sig.,-,-,-,
glutaryl-Coenzyme A dehydrogenase,GCDH,2639,Amino Acid,Amino Acid*,8,Down,Yes,"0,0005","0,059",-,-,-,
alanine-glyoxylate aminotransferase,AGXT,189,Amino Acid,Amino Acid*,8,Down,Yes,"0,0011","0,011",-,-,-,
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,GNE,10020,Aminosugar,Others,8,-,Yes,"0,0238",not sig.,-,-,-,
UDP-N-acteylglucosamine pyrophosphorylase 1,UAP1,6675,Aminosugar,Others,6,-,Yes,"0,0725","0,019",-,-,-,
"methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria",MMACHC,25974,B12,Others,6,-,Yes,"0,0006",not sig.,-,-,-,
3-hydroxyisobutyryl-Coenzyme A hydrolase,HIBCH,26275,BCAAs,Amino Acid*,7,Down,Yes,"0,009",not sig.,-,-,-,
dihydrolipoamide branched chain transacylase E2,DBT,1629,BCAAs,Amino Acid*,8,Down,Yes,not sig.,not sig.,-,-,-,
"branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease)",BCKDHB,594,BCAAs,Amino Acid*,8,Down,Yes,"0,0135","0,0092",-,none in any cancer,-,
isovaleryl Coenzyme A dehydrogenase,IVD,3712,BCAAs,Amino Acid*,8,Down,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
"branched chain keto acid dehydrogenase E1, alpha polypeptide",BCKDHA,593,BCAAs,Amino Acid*,7,Down,Yes,"0,0081",not sig.,-,-,-,
GTP cyclohydrolase 1 (dopa-responsive dystonia),GCH1,2643,BH4,Others,8,-,Yes,not sig.,"0,036",-,-,-,
quinoid dihydropteridine reductase,QDPR,5860,BH4,Others,7,Down,Yes,"0,0035","0,0071",-,-,-,
bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase),BAAT,570,Bile Acid,Others,7,-,Yes,"Showed trend, P>0.1","0,018",-,Downregulated in livers by chronic alcohol consumption,https://www.ncbi.nlm.nih.gov/pubmed/?term=BAAT+hcc,
"glucose-6-phosphatase, catalytic subunit",G6PC,2538,Carbohydrate Storage,Gluconeogenesis,6,-,Yes,"0,0015","0,00081887","Wang et al., 2012",Reduced in HCCs compared with matching peritumoral livers,https://www.ncbi.nlm.nih.gov/pubmed/22318941 ,
"fructose-1,6-bisphosphatase 1",FBP1,2203,Carbohydrate Storage,Gluconeogenesis,7,Down,Yes,0.0013,"0,000355411","Chen et al., 2011",Promoter hypermethylation mediates its downregulation,https://www.ncbi.nlm.nih.gov/pubmed/22039417 ,
phosphoenolpyruvate carboxykinase 1 (soluble),PCK1,5105,Carbohydrate Storage,Gluconeogenesis,7,Down,Yes,"0,0245","0,00785735","Wang et al., 2012",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/22318941 ,
phosphoenolpyruvate carboxykinase 2 (mitochondrial),PCK2,5106,Carbohydrate Storage,Gluconeogenesis,7,Down,Yes,<0.0001,"0,00683736","Liu et al., 2012",Level is associated with carcinoma cell proliferation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/23205112 ,
UDP-glucose pyrophosphorylase 2,UGP2,7360,Carbohydrate Storage,Others,7,Down,Yes,"0,0014",not sig.,"Tan et al., 2014",Related to relapse of tumor,https://www.ncbi.nlm.nih.gov/pubmed/24946162,
glycogen synthase 2 (liver),GYS2,2998,Carbohydrate Storage,Others,7,Down,Yes,"Showed trend, P>0.1","0,057",-,-,-,
lecithin-cholesterol acyltransferase,LCAT,3931,Cholesterol,Cholesterol,8,-,Yes,"0,0165","0,0036","Tahara et al., 1993 ","Plasma LCAT activity decreased with progression of hepatocellular damage, no difference in control vs hcc",https://www.ncbi.nlm.nih.gov/pubmed/?term=LCAT+hcc,
carnitine acetyltransferase,CRAT,1384,Cofactor,Others,6,-,Yes,not sig.,not sig.,"Yang et al., 2015",Regulated by miRNAs ,https://www.ncbi.nlm.nih.gov/pubmed/?term=CRAT+hcc,
folate hydrolase (prostate-specific membrane antigen) 1,FOLH1,2346,Cofactor,Others,8,-,Yes,not sig.,"0,0319872",-,-,-,
gephyrin,GPHN,10243,Cofactor,Others,8,-,Yes,not sig.,not sig.,-,-,-,
"butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1",BBOX1,8424,Cofactor,Others,8,Down,Yes,not sig.,not sig.,-,-,-,
"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",SDHA,6389,Complex II,OXPHOS,7,Down,Yes,not sig.,not sig.,-,-,-,
"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",SDHB,6390,Complex II,OXPHOS,7,Down,Yes,not sig.,"0,053","Shimizu et al., 2014",Decreased in HCC,http://www.ncbi.nlm.nih.gov/pubmed/24203292 ,
guanidinoacetate N-methyltransferase,GAMT,2593,Creatine,Others,8,Down,Yes,"0,0386","0,0026",-,-,-,
glycine amidinotransferase (L-arginine:glycine amidinotransferase),GATM,2628,Creatine,Others,6,Down,Yes,not sig.,< 0.0001,-,-,-,
"cysteine dioxygenase, type I",CDO1,1036,Cysteine,Amino Acid*,7,-,Yes,"0,0014",< 0.0001,"Yang et al., 2014",Suppressed by promoter methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/24646840 ,
cysteine sulfinic acid decarboxylase,CSAD,51380,Cysteine,Amino Acid*,8,-,Yes,"Showed trend, P>0.1","0,023","Kishimoto et al., 1996",Overexpression stimulates hepatocarcinogenesis,https://www.ncbi.nlm.nih.gov/pubmed/?term=CSAD+hcc,
cystathionine-beta-synthase,CBS,875,Cysteine,Amino Acid*,8,Down,Yes,"0,0141",not sig.,"Kim et al., 2009",Downregulated in HCC and associated with poor prognosis,https://www.ncbi.nlm.nih.gov/pubmed/19424622 ,
sulfite oxidase,SUOX,6821,Cysteine,Amino Acid*,7,Down,Yes,"< 0,0001",not sig.,"Jin et al., 2013",Prognostic marker in HCC,https://www.ncbi.nlm.nih.gov/pubmed/23665285,
cystathionase (cystathionine gamma-lyase),CTH,1491,Cysteine,Amino Acid*,7,Down,Yes,"0,0039",not sig.,-,-,-,
prenylcysteine oxidase 1,PCYOX1,51449,Cysteine,Amino Acid*,7,Down,Yes,not sig.,not sig.,-,-,-,
carboxylesterase 3 (brain),CES3,23491,Detox,Detox,6,-,Yes,excluded ,-,"Matsubara et al., 2012",Downregulated in dioxin- and diet-induced steatohepatitis.,https://www.ncbi.nlm.nih.gov/pubmed/23140643 ,
flavin containing monooxygenase 3,FMO3,2328,Detox,Detox,6,-,Yes,"0,0065","0,00012","Lee et al., 2015",SNP related to sorafenib response,https://www.ncbi.nlm.nih.gov/pubmed/?term=FMO3+hcc,
butyrylcholinesterase,BCHE,590,Detox,Detox,8,-,Yes,not sig.,not sig.,"Pohanka, 2013",Increased activity ,http://www.ncbi.nlm.nih.gov/pubmed/24329513 ,
flavin containing monooxygenase 4,FMO4,2329,Detox,Detox,6,-,Yes,"0,0011","0,0092",-,-,-,
"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))",SOD1,6647,Detox,Detox,7,Down,Yes,"0,0535","0,021","Elchuri et al., 2015",SOD deficiency leads to oxidative damage and HCC later in life,https://www.ncbi.nlm.nih.gov/pubmed/15531919,
carboxylesterase 1 (monocyte/macrophage serine esterase 1),CES1,1066,Detox,Detox,7,Down,Yes,"0,055",not sig.,-,-,-,
Catalase,CAT,847,Detox,Detox,7,Down,Yes,"0,0053",< 0.0001,"Liu et al., 2015",Associated with increased risk of HBV-HCC in Guangxi population,http://www.ncbi.nlm.nih.gov/pubmed/25837767 ,
"epoxide hydrolase 2, cytoplasmic",EPHX2,2053,Detox,Detox,7,Down,Yes,"0,0032","0,010",-,-,-,
thiopurine S-methyltransferase,TPMT,7172,Detox,Detox,8,Down,Yes,"0,0032",not sig.,-,-,-,
"acyl-Coenzyme A oxidase 1, palmitoyl",ACOX1,51,Fatty Acid,Fatty Acid,6,-,Yes,not sig.,"0,031","Li et al., 2015",Reprogrammed fatty acid oxidation mediated by ACOX1 in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ACOX1+hcc,
"lipase, hepatic",LIPC,3990,Fatty Acid,Fatty Acid,8,-,Yes,not sig.,"0,0023",-,-,-,
"lipase, endothelial",LIPG,9388,Fatty Acid,Fatty Acid,8,-,Yes,not sig.,not sig.,-,-,-,
"enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase",EHHADH,1962,Fatty Acid,Fatty Acid,7,-,Yes,"0,0115","0,0055","Suto et al., 1999",Downregulated in HCC and a possible marker,https://www.ncbi.nlm.nih.gov/pubmed/10190314 ,
malonyl-CoA decarboxylase,MLYCD,23417,Fatty Acid,Fatty Acid,8,-,Yes,"< 0,0001",not sig.,-,1 in all cancers,-,
enoyl Coenzyme A hydratase domain containing 3,ECHDC3,79746,Fatty Acid,Fatty Acid,6,-,Yes,not sig.,not sig.,-,-,-,
acyl-Coenzyme A binding domain containing 4,ACBD4,79777,Fatty Acid,Fatty Acid,8,-,Yes,"0,0012",not sig.,-,-,-,
fatty acid amide hydrolase,FAAH,2166,Fatty Acid,Fatty Acid,6,-,Yes,"0,0015",not sig.,-,-,-,
phytanoyl-CoA 2-hydroxylase,PHYH,5264,Fatty Acid,Fatty Acid,7,-,Yes,"0,0302","0,0018",-,-,-,
carnitine palmitoyltransferase II,CPT2,1376,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0526",not sig.,-,-,-,
acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase),ACAA1,30,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0846","0,016","Liu et al., 2015",A hub gene in HCC progression,http://www.ncbi.nlm.nih.gov/pubmed/25768320,
acyl-CoA synthetase long-chain family member 1,ACSL1,2180,Fatty Acid,Fatty Acid,8,Down,Yes,not sig.,"0,038","Cui et al., 2015",Overexpressed in HCC regions compared to non-tumoral regions,https://www.ncbi.nlm.nih.gov/pubmed/25592151,
acyl-CoA synthetase long-chain family member 5,ACSL5,51703,Fatty Acid,Fatty Acid,6,Down,Yes,not sig.,"0,0041","Muir et al., 2013",ACSL5 overexpressed in NASH-based HCC compared to ACSL1 which highly downregulated,https://www.ncbi.nlm.nih.gov/pubmed/23749645 ,
"enoyl Coenzyme A hydratase, short chain, 1, mitochondrial",ECHS1,1892,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0789","0,0039","Liu et al., 2015",Upregulated during HCC progression,https://www.ncbi.nlm.nih.gov/pubmed/25768320 ,
"acyl-Coenzyme A dehydrogenase, very long chain",ACADVL,37,Fatty Acid,Fatty Acid,6,Down,Yes,"0,0127",not sig.,"Huang et al., 2014",Decreased expression predicts patient mortality,http://www.ncbi.nlm.nih.gov/pubmed/25242319 ,
"acyl-Coenzyme A oxidase 2, branched chain",ACOX2,8309,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0003","0,0034","Tanaka et al., 2013",Downregulated and significantly correlated with the progression of de-differentiation,https://www.ncbi.nlm.nih.gov/pubmed/23178736 ,
acyl-CoA synthetase medium-chain family member 5,ACSM5,54988,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0104",not sig.,-,-,-,
microsomal triglyceride transfer protein,MTTP,4547,Fatty Acid,Fatty Acid,6,Down,Yes,"0,0134","0,057","Tsai et al., 2012",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/22820290 ,
acetyl-Coenzyme A carboxylase beta,ACACB,32,Fatty Acid,Fatty Acid,8,Down,Yes,not sig.,not sig.,-,-,-,
"acyl-Coenzyme A dehydrogenase, long chain",ACADL,33,Fatty Acid,Fatty Acid,8,Down,Yes,not sig.,not sig.,-,-,-,
"acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain",ACADM,34,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0007","0,041",-,-,-,
"acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain",ACADS,35,Fatty Acid,Fatty Acid,8,Down,Yes,not sig.,"0,024",-,-,-,
peroxisomal trans-2-enoyl-CoA reductase,PECR,55825,Fatty Acid,Fatty Acid,6,Down,Yes,"0,0022",< 0.0001,-,none in any cancer,-,
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase),ACAA2,10449,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0018","0,053",-,-,-,
"acyl-Coenzyme A dehydrogenase, short/branched chain",ACADSB,36,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0212","0,034",-,-,-,
acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase),ACAT1,38,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0264","0,034",-,-,-,
acyl-CoA synthetase medium-chain family member 3,ACSM3,6296,Fatty Acid,Fatty Acid,7,Down,Yes,"0,002",not sig.,-,-,-,
enoyl Coenzyme A hydratase domain containing 2,ECHDC2,55268,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0004","0,057",-,-,-,
electron-transferring-flavoprotein dehydrogenase,ETFDH,2110,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0028",not sig.,-,-,-,
sterol carrier protein 2,SCP2,6342,Fatty Acid,Fatty Acid,8,Down,Yes,"0,0227","0,012",-,-,-,
hydroxyacyl-Coenzyme A dehydrogenase,HADH,3033,Fatty Acid,Fatty Acid,7,Down,Yes,"0,0228",not sig.,-,-,-,
"cytochrome P450, family 4, subfamily A, polypeptide 22",CYP4A22,284541,Fatty Acid,Xenobiotics/Steroid,6,-,Yes,excluded ,-,"Udali et al., 2015",Repressed by DNA methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25945129 ,
"cytochrome P450, family 4, subfamily F, polypeptide 12",CYP4F12,66002,Fatty Acid,Xenobiotics/Steroid,7,-,Yes,not sig.,"0,026","Goldstein et al., 2013",Upregulated by chemotherapeutics,https://www.ncbi.nlm.nih.gov/pubmed/?term=CYP4F12+liver+cancer,
"cytochrome P450, family 4, subfamily F, polypeptide 2",CYP4F2,8529,Fatty Acid,Xenobiotics/Steroid,7,-,Yes,not sig.,"0,011","Tsunedomi et al., 2005",Slightly lowered in HCC,https://www.ncbi.nlm.nih.gov/pubmed/16077914 ,
"cytochrome P450, family 4, subfamily F, polypeptide 3",CYP4F3,4051,Fatty Acid,Xenobiotics/Steroid,8,-,Yes,"0,0007","< 0,0001","Tsunedomi et al., 2005",Found several CYPs to be suppressed in conjunction with HCC progression,http://www.ncbi.nlm.nih.gov/pubmed/16077914 ,
"cytochrome P450, family 4, subfamily A, polypeptide 11",CYP4A11,1579,Fatty Acid,Xenobiotics/Steroid,7,Down,Yes,"0,0001","0,00038",Chen et al. 2014 ,Decreased in HCC,http://www.ncbi.nlm.nih.gov/pubmed/25024626,
"5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)",MTHFS,10588,Folate,Others,8,Down,Yes,"0,0028","0,0015",-,genetic polymorphism of MTHFS is consistently associated with HCC risk,https://www.ncbi.nlm.nih.gov/pubmed/?term=MTHFS+hcc,
serine hydroxymethyltransferase 1 (soluble),SHMT1,6470,Folate,Others,8,Down,Yes,not sig.,not sig.,"Udali et al., 2015",Repressed by DNA methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25945129,
"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",MTHFD1,4522,Folate,Others,7,Down,Yes,"0,0254",not sig.,-,-,-,
"glutaminase 2 (liver, mitochondrial)",GLS2,27165,Glutamate,Glutamine,7,Down,Yes,"Showed trend P>0.1, p.d","0,0335156","Chen et al., 2016; Yu et al., 2015",Prognostic biomarker in HCC,https://www.ncbi.nlm.nih.gov/pubmed/27079415,http://www.ncbi.nlm.nih.gov/pubmed/25844758
glutamate dehydrogenase 1,GLUD1,2746,Glutamate,Glutamine,7,Down,Yes,not sig.,"0,00041",-,-,-,
glutathione S-transferase A1,GSTA1,2938,Glutathione,Glutathione,6,-,Yes,"Showed trend, P>0.1","0,000805269","Chen et al., 2010",No association between the GSTA1 gene polymorphism and HCC susceptibility ,https://www.ncbi.nlm.nih.gov/pubmed/20331903 ,
microsomal glutathione S-transferase 2,MGST2,4258,Glutathione,Glutathione,6,-,Yes,"0,0493","0,0923652",-,-,-,
hydroxyacylglutathione hydrolase,HAGH,3029,Glutathione,Glutathione,7,Down,Yes,"0,0015","0,00420281",-,-,-,
"ST3 beta-galactoside alpha-2,3-sialyltransferase 6",ST3GAL6,10402,Glycan,Glycan,8,-,Yes,"Showed trend, P>0.1",not sig.,"Souady et al., 2011",Downreg. in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ST3GAL6+hcc,
"ST6 beta-galactosamide alpha-2,6-sialyltranferase 1",ST6GAL1,6480,Glycan,Glycan,6,Up,Yes,"not sig., however p.d.","0,064","Souady et al., 2011; Poon et al., 2005","Downregulated in HCC; low expression associated with shorter overall survival (Poon et al., 2005)",https://www.ncbi.nlm.nih.gov/pubmed/21147760 ,https://www.ncbi.nlm.nih.gov/pubmed/16425369
"chitobiase, di-N-acetyl-",CTBS,1486,Glycan,Glycan,8,-,Yes,"0,0203",not sig.,-,-,-,
"glucosidase, beta, acid 3 (cytosolic)",GBA3,57733,Glycan,Glycan,7,-,Yes,"0,0857",not sig.,-,-,-,
"phosphatidylinositol glycan anchor biosynthesis, class V",PIGV,55650,Glycan Anchor,Glycan,7,-,Yes,"0,0614","0,047",-,-,-,
"ER degradation enhancer, mannosidase alpha-like 1",EDEM1,9695,Glycan Degradation,Glycan,6,-,Yes,not sig.,not sig.,"Wang et al., 2014",miR-581 targets EDEM in HBV infection which affects HCC development,https://www.ncbi.nlm.nih.gov/pubmed/?term=EDEM1+hcc,
"mannosidase, alpha, class 1C, member 1",MAN1C1,57134,Glycan Degradation,Glycan,8,-,Yes,"0,0724",not sig.,-,-,-,
hyaluronoglucosaminidase 1,HYAL1,3373,Glycan Degradation,Glycan,8,-,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
sarcosine dehydrogenase,SARDH,1757,Glycine,Amino Acid*,8,Down,Yes,"0,0079",not sig.,"Lim et al., 2002",Protein-level downregulated in HCC; potential biomarker,https://www.ncbi.nlm.nih.gov/pubmed/?term=11866469,
Betaine-homocysteine methyltransferase,BHMT,635,Glycine,Amino Acid*,7,Down,Yes,"0,0057","0,00040","Jin et al., 2015",Downregulated in HCC and is associated with poor prognosis.,http://www.ncbi.nlm.nih.gov/pubmed/26592251 ,
betaine-homocysteine methyltransferase 2,BHMT2,23743,Glycine,Amino Acid*,6,Down,Yes,"0,0128","0,032",-,-,-,
"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1",PFKFB1,5207,Glycolysis,Glycolysis,6,-,Yes,"0,0202",not sig.,-,-,-,
"aldolase B, fructose-bisphosphate",ALDOB,229,Glycolysis,Glycolysis,8,Down,Yes,"0,0022, also p.d.","0,0340178","Tao et al., 2015","Downregulated and is associated with a poor prognosis for HCC patients, might be considered a prognostic biomarker ",https://www.ncbi.nlm.nih.gov/pubmed/26376879 ,
phosphoglucomutase 1,PGM1,5236,Glycolysis,Glycolysis,8,Down,Yes,not sig.,not sig.,-,-,-,
hydroxyacid oxidase (glycolate oxidase) 1,HAO1,54363,Glyoxylate,Others,7,-,Yes,"0,0009","0,00054",-,-,-,
hydroxyacid oxidase 2 (long chain),HAO2,51179,Glyoxylate,Others,8,Down,Yes,"0,0152",not sig.,"Mattu et al., 2016",Downregulated in HCC; reintroduction impairs tumorigenesis; its dysregulation is a very early event; may be a useful diagnostic/prognostic marker in clinical HCC.,http://www.ncbi.nlm.nih.gov/pubmed/26658681 ,
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,NDST3,9348,Heparin Sulfate,Others,6,-,Yes,not sig.,not sig.,-,-,-,
histamine N-methyltransferase,HNMT,3176,Histidine,Amino Acid*,7,-,Yes,"0,0887",not sig.,-,Induced in HepG2 cells upon treatment with benzo[a]pyrene treatment https://www.ncbi.nlm.nih.gov/pubmed/22138271,-,
formiminotransferase cyclodeaminase,FTCD,10841,Histidine,Amino Acid*,7,Down,Yes,"0,002","0,0011","Seimiya et al., 2008",Downregulated in HCC and can be used as a biomarker,https://www.ncbi.nlm.nih.gov/pubmed/18571811 ,
membrane metallo-endopeptidase,MME,4311,Hormone,Others,8,-,Yes,not sig.,not sig.,"Archer et al., 2010",Different methylation pattern in HCC,https://www.ncbi.nlm.nih.gov/pubmed/20165882,
"phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)",PIK3R1,5295,Inositol Phosphate,Others,8,-,Yes,not sig.,"0,0020","Taniguchi et al., 2010",Decreased in liver cancers,https://www.ncbi.nlm.nih.gov/pubmed/20530665 ,
"solute carrier family 39 (metal ion transporter), member 8",SLC39A8,64116,Ion Transport,Ion Transport,8,-,Yes,not sig.,not sig.,"Liuzzi and Yoo, 2013",Regulated by alcohol in hepatoma cells,https://www.ncbi.nlm.nih.gov/pubmed/?term=SLC39A8+liver+cancer,
"solute carrier family 31, member 1",SLC31A1,1317,Ion Transport,Ion Transport,7,-,Yes,not sig.,not sig.,-,-,-,
"solute carrier family 39 (zinc transporter), member 14",SLC39A14,23516,Ion Transport,Ion Transport,8,-,Yes,not sig.,not sig.,"Franklin et al., 2012",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/21373779 ,
transferrin,TF,7018,Ion Transport,Ion Transport,8,Up,Yes,not sig.,not sig.,"Sakurai et al., 2014",Significantly higher in HCC samples than in adjacent non-tumor tissue,http://www.ncbi.nlm.nih.gov/pubmed/24901155 ,
cyclic nucleotide gated channel alpha 1,CNGA1,1259,Ion Transport,Ion Transport,7,-,Yes,"0,0002","0,023",-,-,-,
"potassium inwardly-rectifying channel, subfamily J, member 8",KCNJ8,3764,Ion Transport,Ion Transport,7,-,Yes,"0,0109","0,018",-,-,-,
"3-hydroxybutyrate dehydrogenase, type 1",BDH1,622,Ketone Bodies,Ketogenesis,7,Down,Yes,"0,0082","0,00016894",-,-,-,
"3-hydroxybutyrate dehydrogenase, type 2",BDH2,56898,Ketone Bodies,Ketogenesis,7,Down,Yes,not sig.,not sig.,-,-,-,
oxoglutarate dehydrogenase-like,OGDHL,55753,Krebs,TCA,7,Down,Yes,"Showed trend, P>0.1","0,025",-,-,-,
pyruvate carboxylase,PC,5091,Krebs,TCA,7,Down,Yes,not sig.,"0,025","Chang and Morris, 1973",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/4353477 ,
"succinate-CoA ligase, GDP-forming, beta subunit",SUCLG2,8801,Krebs,TCA,8,Down,Yes,"0,0735",not sig.,-,-,-,
"aconitase 1, soluble",ACO1,48,Krebs,TCA,7,Down,Yes,"0,0211",not sig.,-,-,-,
pipecolic acid oxidase,PIPOX,51268,Lysine,Amino Acid*,7,-,Yes,"0,0007","0,00011",-,-,-,
aminoadipate-semialdehyde synthase,AASS,10157,Lysine,Amino Acid*,7,Down,Yes,"0,0018",not sig.,-,-,-,
phosphatidylethanolamine N-methyltransferase,PEMT,10400,Membrane Lipid,Membrane Lipid,7,-,Yes,not sig.,"0,019","Tessitore et al., 2003 ",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/12931022 ,
choline/ethanolamine phosphotransferase 1,CEPT1,10390,Membrane Lipid,Membrane Lipid,6,-,Yes,not sig.,not sig.,-,-,-,
lipin 2,LPIN2,9663,Membrane Lipid,Membrane Lipid,7,-,Yes,"0,0154","0,0027",-,-,-,
monoacylglycerol O-acyltransferase 2,MOGAT2,80168,Membrane Lipid,Membrane Lipid,7,-,Yes,not sig.,not sig.,-,-,-,
phosphatidic acid phosphatase type 2B,PPAP2B,8613,Membrane Lipid,Membrane Lipid,7,-,Yes,not sig.,"0,020",-,-,-,
glycerol-3-phosphate dehydrogenase 1 (soluble),GPD1,2819,Membrane Lipid,Membrane Lipid,8,Down,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
"methionine adenosyltransferase I, alpha",MAT1A,4143,Methionine,Amino Acid*,8,Down,Yes,"0,0167",< 0.0001,"Frau et al., 2013","Downregulated in HCC, predicts survival, biomarker",https://www.ncbi.nlm.nih.gov/pubmed/22318685,
methionine sulfoxide reductase A,MSRA,4482,Methionine,Amino Acid*,8,Down,Yes,"0,0086",not sig.,"Lei et al., 2007",Downregulated in HCC; metastasis suppressor,http://www.ncbi.nlm.nih.gov/pubmed/17784942 ,
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial),HMGCS2,3158,Mevalonate,Cholesterol,7,Down,Yes,"0,0002","0,0021",-,-,-,
N-acetyltransferase 2 (arylamine N-acetyltransferase),NAT2,10,Multipurpose,Multipurpose,8,-,Yes,"0,0539",not sig.,"Yu et al., 2000",A significant association between NAT2 genetic polymorphism and HCC,http://www.ncbi.nlm.nih.gov/pubmed/11034589 ,
abhydrolase domain containing 2,ABHD2,11057,Multipurpose,Multipurpose,7,-,Yes,not sig.,not sig.,-,-,-,
abhydrolase domain containing 6,ABHD6,57406,Multipurpose,Multipurpose,8,-,Yes,not sig.,not sig.,-,-,-,
arylsulfatase D,ARSD,414,Multipurpose,Multipurpose,6,-,Yes,not sig.,not sig.,-,-,-,
"carbonic anhydrase VA, mitochondrial",CA5A,763,Multipurpose,Multipurpose,6,-,Yes,not sig.,not sig.,-,-,-,
abhydrolase domain containing 10,ABHD10,55347,Multipurpose,Multipurpose,6,-,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
"alcohol dehydrogenase 1A (class I), alpha polypeptide",ADH1A,124,Multipurpose,Multipurpose,7,Down,Yes,"0,0651","0,00038","Udali et al., 2015",Repressed by DNA methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25945129,
"Alcohol dehydrogenase 1B (class I), beta polypeptide",ADH1B,125,Multipurpose,Multipurpose,7,Down,Yes,"0,0008","0,00015","Udali et al., 2015", Repressed by DNA methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25945129,
"alcohol dehydrogenase 1C (class I), gamma polypeptide",ADH1C,126,Multipurpose,Multipurpose,6,Down,Yes,"0,0071","0,039","Liu et al., 2007 ",Downreg. in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ALDH6A1+hcc,
"aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)",AKR7A3,22977,Multipurpose,Multipurpose,7,Down,Yes,"0,0169",not sig.,"Albrethsen et al., 2011",Upregulated in hepatomas,https://www.ncbi.nlm.nih.gov/pubmed/?term=AKR7A3+hcc,
"aldehyde dehydrogenase 1 family, member L1",ALDH1L1,10840,Multipurpose,Multipurpose,6,Down,Yes,"0.0032, p.d.","0,0058","Chen et al., 2012",Decreased expression associated with poor prognosis,https://www.ncbi.nlm.nih.gov/pubmed/?term=ALDH1L1+hcc,
"aldehyde dehydrogenase 6 family, member A1",ALDH6A1,4329,Multipurpose,Multipurpose,8,Down,Yes,"0,0062",not sig.,"Liu et al., 2007 ",Downreg. in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ALDH6A1+hcc,
"aldehyde dehydrogenase 8 family, member A1",ALDH8A1,64577,Multipurpose,Multipurpose,8,Down,Yes,not sig.,"0,0016","Grinberg et al., 2014",Toxigenomics screening to predict biomarkers for toxicity,http://www.ncbi.nlm.nih.gov/pubmed/?term=SULT1C2+hcc,
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria),HMGCL,3155,Multipurpose,Multipurpose,7,Down,Yes,"0,068",not sig.,-,-,-,
alcohol dehydrogenase 6 (class V),ADH6,130,Multipurpose,Multipurpose,7,Down,Yes,"0,0001","0,00013",-,-,-,
"glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)",GOT2,2806,Multipurpose,Multipurpose,7,Down,Yes,"0,0001",not sig.,-,-,-,
Monoamine oxidase B,MAOB,4129,Multipurpose,Multipurpose,6,Down,Yes,"0,001","0,029",-,-,-,
"aldehyde dehydrogenase 7 family, member A1",ALDH7A1,501,Multipurpose,Multipurpose,6,Down,Yes,"0,0011","0,0063",-,-,-,
carbonyl reductase 4,CBR4,84869,Multipurpose,Multipurpose,8,Down,Yes,"0,004",not sig.,-,-,-,
aldehyde dehydrogenase 2 family (mitochondrial),ALDH2,217,Multipurpose,Multipurpose,8,Down,Yes,"0,0062",not sig.,"Jin et al., 2015",Protein level is low in patient HCC than in peritumor or normal liver tissues. Functions as a tumour suppressor by maintaining genomic stability in the liver.,http://www.ncbi.nlm.nih.gov/pubmed/26150517,
"aldehyde dehydrogenase 9 family, member A1",ALDH9A1,223,Multipurpose,Multipurpose,7,Down,Yes,"0,0477","0,052",-,-,-,
"aldehyde dehydrogenase 1 family, member B1",ALDH1B1,219,Multipurpose,Multipurpose,7,Down,Yes,"0,0554",not sig.,-,-,-,
glutathione transferase zeta 1 (maleylacetoacetate isomerase),GSTZ1,2954,Multipurpose,Multipurpose,7,Down,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
nicotinamide nucleotide transhydrogenase,NNT,23530,NAD,NAD,6,-,Yes,"0,0046","0,04178",-,-,-,
quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating)),QPRT,23475,NAD,NAD,6,Down,Yes,not sig.,not sig.,-,-,-,
dopamine beta-hydroxylase (dopamine beta-monooxygenase),DBH,1621,Neurotransmitter,Others,8,-,Yes,not sig.,not sig.,"Goldstein et al., 1973",DBH activity in serum in patients with hepatoma,https://www.ncbi.nlm.nih.gov/pubmed/4362767,
4-aminobutyrate aminotransferase,ABAT,18,Neurotransmitter,Others,8,Down,Yes,"0,0093","0,0034","Reis et al., 2015",Biomarker in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ABAT+hcc,
ectonucleotide pyrophosphatase/phosphodiesterase 1,ENPP1,5167,Nucleotide,Nucleotide,7,-,Yes,not sig.,not sig.,-,-,-,
nudix (nucleoside diphosphate linked moiety X)-type motif 7,NUDT7,283927,Nucleotide,Nucleotide,8,-,Yes,not sig.,not sig.,-,-,-,
"TDP-glucose 4,6-dehydratase",TGDS,23483,Nucleotide Sugar,Nucleotide,6,-,Yes,"0,0528","0,036",-,-,-,
APOBEC1 complementation factor,A1CF,29974,Other,Others,8,-,Yes,"0,0722","0,00060",-,-,-,
paraoxonase 3,PON3,5446,Other,Others,7,Down,Yes,"0,0047","0,0083","AkkÄ±z et al., 2013",Focusing on SNPs in PON1,https://www.ncbi.nlm.nih.gov/pubmed/?term=hcc+PON2,
glycine-N-acyltransferase,GLYAT,10249,Other,Others,7,Down,Yes,"0,0002","0,033","Matsuo et al., 2012",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/22475485 ,
glycine N-methyltransferase,GNMT,27232,Other,Others,8,Down,Yes,"0,0009",not sig.,"Huidobro et al., 2013",DNA hypermethylation  represses  GNMT in HCC ,http://www.ncbi.nlm.nih.gov/pubmed/23475283 ,
paraoxonase 1,PON1,5444,Other,Others,7,Down,Yes,"0,0072",not sig.,"Huang et al., 2013",PON1 expression in tumor cells is inversely correlated with the extent of vascular invasion HCC ,http://www.ncbi.nlm.nih.gov/pubmed/23442176 ,
frataxin,FXN,2395,Other,Others,8,Down,Yes,not sig.,not sig.,-,-,-,
"nitrilase family, member 2",NIT2,56954,Other,Others,6,Down,Yes,not sig.,"0,0058",-,-,-,
2-deoxyribose-5-phosphate aldolase homolog (C. elegans),DERA,51071,Pentose Phosphate,PPP,7,-,Yes,"0,0075","0,0834438",-,-,-,
D-dopachrome tautomerase,DDT,1652,Pigment,Others,7,Down,Yes,"0,091","0,019",-,-,-,
polyamine oxidase (exo-N4-amino),PAOX,196743,Polyamine,Others,6,-,Yes,not sig.,not sig.,-,-,-,
"aminolevulinate, delta-, synthase 1",ALAS1,211,Porphyrin,Others,6,-,Yes,"0,0027","0,014","Sehgal et al., 2013",not related to HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=ALAS1+hcc,
"aldehyde dehydrogenase 4 family, member A1",ALDH4A1,8659,Proline,Amino Acid*,6,Down,Yes,not sig.,not sig.,-,-,-,
proline dehydrogenase (oxidase) 2,PRODH2,58510,Proline,Amino Acid*,8,Down,Yes,not sig.,"0,0048",-,-,-,
methylmalonyl Coenzyme A mutase,MUT,4594,Propanoate,Others,7,Down,Yes,"0,0067","0,0051",-,-,-,
"propionyl Coenzyme A carboxylase, alpha polypeptide",PCCA,5095,Propanoate,Others,7,Down,Yes,"Showed trend, P>0.1","0,061",-,-,-,
"Propionyl Coenzyme A carboxylase, beta polypeptide",PCCB,5096,Propanoate,Others,6,Down,Yes,"0,0058","0,020",-,-,-,
xanthine dehydrogenase,XDH,7498,Purine,Nucleotide,7,Down,Yes,"0,0047","0,035","Pan et al., 2008",dysregulated in adrenal gland of H22 liver cancer mice,https://www.ncbi.nlm.nih.gov/pubmed/?term=XDH+liver+cancer,
adenosine kinase,ADK,132,Purine,Nucleotide,8,Down,Yes,not sig.,"0,027",-,-,-,
dihydroorotate dehydrogenase,DHODH,1723,Pyrimidine,Nucleotide,7,Up,Yes,not sig.,not sig.,-,-,-,
"ureidopropionase, beta",UPB1,51733,Pyrimidine,Nucleotide,7,Down,Yes,"0,0053","0,0011","Awan et al., 2015",Target of circulating miRNA ,https://www.ncbi.nlm.nih.gov/pubmed/?term=UPB1+hcc,
dihydropyrimidinase,DPYS,1807,Pyrimidine,Nucleotide,7,Down,Yes,"0,0455",< 0.0001,-,-,-,
dimethylarginine dimethylaminohydrolase 1,DDAH1,23576,Reactive Oxygen,Others,6,Down,Yes,not sig.,"0,044",-,-,-,
aldehyde oxidase 1,AOX1,316,Reactive Oxygen,Others,8,Down,Yes,not sig.,"0,0046",-,-,-,
dehydrogenase/reductase (SDR family) member 12,DHRS12,79758,Redox,Redox,6,-,Yes,"0,0141",not sig.,-,-,-,
dehydrogenase E1 and transketolase domain containing 1,DHTKD1,55526,Redox,Redox,6,-,Yes,"0,0167","0,052",-,-,-,
cytochrome b5 type A (microsomal),CYB5A,1528,Redox,Redox,8,Down,Yes,"0,0026",< 0.0001,"Khan et al., 2013",Downregulated in HCC suggests its possible role in disease progression.,http://www.ncbi.nlm.nih.gov/pubmed/23724895 ,
dehydrogenase/reductase (SDR family) member 1,DHRS1,115817,Redox,Redox,7,Down,Yes,"< 0,0001","0,0031",-,-,-,
ferredoxin 1,FDX1,2230,Redox,Redox,7,Down,Yes,"0,0081","0,047",-,-,-,
adenylate cyclase 1 (brain),ADCY1,107,Signalling,Others,8,-,Yes,"0,0375",not sig.,-,-,-,
"phosphodiesterase 2A, cGMP-stimulated",PDE2A,5138,Signalling,Others,8,-,Yes,not sig.,"0,011",-,-,-,
phosphodiesterase 7B,PDE7B,27115,Signalling,Others,6,-,Yes,not sig.,not sig.,-,-,-,
"solute carrier family 1 (glial high affinity glutamate transporter), member 2",SLC1A2,6506,Small Molecule Transport,S.M. Transport,6,-,Yes,not sig.,"0,062","Sekine et al., 2011","Overexpressed in Conditional knockout mice (B-catenin, HCC Model) ",http://www.ncbi.nlm.nih.gov/pubmed/21216847 ,
"solute carrier family 28 (sodium-coupled nucleoside transporter), member 1",SLC28A1,9154,Small Molecule Transport,S.M. Transport,6,-,Yes,"0,0467",not sig.,"Kim et al., 2015",Gene loss in HCC,http://www.ncbi.nlm.nih.gov/pubmed/25379720 ,
"solute carrier family 38, member 2",SLC38A2,54407,Small Molecule Transport,S.M. Transport,7,-,Yes,not sig.,not sig.,"Kondoh et al., 2007",Either unchanged or downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/17549407 ,
"solute carrier family 38, member 4",SLC38A4,55089,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0066","0,00053","Kondoh et al., 2007",Either unchanged or downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/17549407 ,
"solute carrier family 7 (cationic amino acid transporter, y+ system), member 2",SLC7A2,6542,Small Molecule Transport,S.M. Transport,6,-,Yes,not sig.,not sig.,"Kondoh et al., 2007",Either unchanged or downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/17549407 ,
aquaporin 9,AQP9,366,Small Molecule Transport,S.M. Transport,6,-,Yes,"0,0001","0,0028","Padma et al., 2009",Downregulated in HCC ,https://www.ncbi.nlm.nih.gov/pubmed/19590626 ,
"solute carrier family 10 (sodium/bile acid cotransporter family), member 1",SLC10A1,6554,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0005","0,0082","Hu et al., 2015",Independently associated with decreased risk of HCC,http://www.ncbi.nlm.nih.gov/pubmed/26642861 ,
"solute carrier family 22 (organic cation transporter), member 1",SLC22A1,6580,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0129",not sig.,"Heise et al., 2012",Downregulation in HCC is associated with tumor progression and a worse patient survival,http://www.ncbi.nlm.nih.gov/pubmed/22439694 ,
"solute carrier family 22 (organic anion transporter), member 7",SLC22A7,10864,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0008",< 0.0001,"Yasui et al., 2014",Reduced expression in noncancerous liver tissue was significantly associated with a high incidence of HCC recurrence,http://www.ncbi.nlm.nih.gov/pubmed/24401597 ,
"solute carrier family 23 (nucleobase transporters), member 2",SLC23A2,9962,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0096","0,0011",-,-,-,
"solute carrier family 2 (facilitated glucose transporter), member 2",SLC2A2,6514,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0002",< 0.0001,-,-,-,
"solute carrier organic anion transporter family, member 1b1",SLCO1B1,10599,Small Molecule Transport,S.M. Transport,7,-,Yes,"Showed trend, P>0.1","0,0022","Vavricka et al., 2004",Not significantly decreased in HCC,http://www.ncbi.nlm.nih.gov/pubmed/14739090 ,
"solute carrier organic anion transporter family, member 1b3",SLCO1B3,28234,Small Molecule Transport,S.M. Transport,8,-,Yes,not sig.,not sig.,"Vavricka et al., 2004",Decreased in 60% of HCC compared to surrounding non-tumor liver tissue,https://www.ncbi.nlm.nih.gov/pubmed/14739090,
aquaporin 7,AQP7,364,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0013",not sig.,-,-,-,
"solute carrier family 16 (monocarboxylic acid transporters), member 2",SLC16A2,6567,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0007","0,0051",-,-,-,
"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",SLC1A1,6505,Small Molecule Transport,S.M. Transport,6,-,Yes,"0,0266",not sig.,-,-,-,
"solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15",SLC25A15,10166,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0003","0,0025",-,none in any cancer,-,
"solute carrier family 27 (fatty acid transporter), member 2",SLC27A2,11001,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0421","0,00054",-,-,-,
"solute carrier family 27 (fatty acid transporter), member 5",SLC27A5,10998,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0003","0,0013",-,-,-,
"solute carrier family 46, member 3",SLC46A3,283537,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0057",not sig.,-,-,-,
"solute carrier family 47, member 1",SLC47A1,55244,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0467","0,013",-,-,-,
"solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12",SLC6A12,6539,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0015","0,015",-,-,-,
"solute carrier organic anion transporter family, member 2b1",SLCO2B1,11309,Small Molecule Transport,S.M. Transport,7,-,Yes,"0,0042","0,00025",-,-,-,
StAR-related lipid transfer (START) domain containing 5,STARD5,80765,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0023",not sig.,-,-,-,
"solute carrier family 4 (anion exchanger), member 4",SLC4A4,8671,Small Molecule Transport,S.M. Transport,8,-,Yes,"0,0706",not sig.,-,-,-,
"solute carrier family 17 (sodium phosphate), member 1",SLC17A1,6568,Small Molecule Transport,S.M. Transport,6,-,Yes,not sig.,"0,017",-,-,-,
"solute carrier family 17 (sodium phosphate), member 2",SLC17A2,10246,Small Molecule Transport,S.M. Transport,8,-,Yes,not sig.,"0,023",-,-,-,
"solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16",SLC25A16,8034,Small Molecule Transport,S.M. Transport,6,-,Yes,not sig.,not sig.,-,none in any cancer,-,
"solute carrier family 25, member 37",SLC25A37,51312,Small Molecule Transport,S.M. Transport,6,-,Yes,not sig.,not sig.,-,-,-,
"solute carrier family 37 (glycerol-6-phosphate transporter), member 4",SLC37A4,2542,Small Molecule Transport,S.M. Transport,7,-,Yes,not sig.,"0,029",-,-,-,
"solute carrier family 6 (neurotransmitter transporter, GABA), member 13",SLC6A13,6540,Small Molecule Transport,S.M. Transport,6,-,Yes,"Showed trend, P>0.1","0,037",-,-,-,
"solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20",SLC25A20,788,Small Molecule Transport,S.M. Transport,8,Down,Yes,"0,001","0,0024",-,-,-,
Sideroflexin 1,SFXN1,94081,Small Molecule Transport,S.M. Transport,6,Down,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
"cytochrome P450, family 1, subfamily A, polypeptide 1",CYP1A1,1543,Steroid,Xenobiotics/Steroid,6,-,Yes,not sig.,not sig.,"Yang et al., 2015",Increase susceptibility to smoking-related HCC,http://www.ncbi.nlm.nih.gov/pubmed/26579440 ,
"cytochrome P450, family 2, subfamily B, polypeptide 6",CYP2B6,1555,Steroid,Xenobiotics/Steroid,6,-,Yes,not sig.,not sig.,"Tsunedomi et al., 2005",Downregulated in HCV-associated HCC and may be served as a marker of progression,https://www.ncbi.nlm.nih.gov/pubmed/16077914 ,
"cytochrome P450, family 2, subfamily C, polypeptide 19",CYP2C19,1557,Steroid,Xenobiotics/Steroid,8,-,Yes,not sig.,not sig.,"Tsunedomi et al., 2005",Significantly lowered in HCC,https://www.ncbi.nlm.nih.gov/pubmed/16077914 ,
"cytochrome P450, family 3, subfamily A, polypeptide 43",CYP3A43,64816,Steroid,Xenobiotics/Steroid,7,-,Yes,<0.0001,"0,0045","Udali et al., 2015",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/25945129 ,
"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",SRD5A2,6716,Steroid,Xenobiotics/Steroid,8,-,Yes,"0,085",not sig.,"Tsunedomi et al., 2010",Downregulated in HCC and can be used as a biomarker,https://www.ncbi.nlm.nih.gov/pubmed/19956849 ,
"cytochrome P450, family 2, subfamily A, polypeptide 7",CYP2A7,1549,Steroid,Xenobiotics/Steroid,6,-,Yes,"0,0346",not sig.,-,-,-,
"Cytochrome P450, family 2, subfamily D, polypeptide 6",CYP2D6,1565,Steroid,Xenobiotics/Steroid,8,-,Yes,not sig.,"0,041","Silvestri et al., 2003",Less frequent in HCC,https://www.ncbi.nlm.nih.gov/pubmed/12569554 ,
"cytochrome P450, family 2, subfamily J, polypeptide 2",CYP2J2,1573,Steroid,Xenobiotics/Steroid,7,-,Yes,"0,0012","0,026","Jiang et al., 2009",A novel biomarker of human tumors?,http://www.ncbi.nlm.nih.gov/pubmed/19550113 ,
"cytochrome P450, family 39, subfamily A, polypeptide 1",CYP39A1,51302,Steroid,Xenobiotics/Steroid,7,-,Yes,not sig.,not sig.,-,-,-,
"cytochrome P450, family 2, subfamily C, polypeptide 18",CYP2C18,1562,Steroid,Xenobiotics/Steroid,8,-,Yes,not sig.,not sig.,-,-,-,
hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse),HSD17B6,8630,Steroid,Xenobiotics/Steroid,8,-,Yes,"0,0018","0,0027",-,-,-,
"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",SRD5A1,6715,Steroid,Xenobiotics/Steroid,7,-,Yes,"0,0038",not sig.,-,-,-,
"cytochrome P450, family 1, subfamily A, polypeptide 2",CYP1A2,1544,Steroid,Xenobiotics/Steroid,7,Down,Yes,"0,0645",not sig.,"Tanaka et al., 2011",Downregulated in HCC and its downregulation predicts reoccurence,https://www.ncbi.nlm.nih.gov/pubmed/22006857,
"cytochrome P450, family 2, subfamily A, polypeptide 6",CYP2A6,1548,Steroid,Xenobiotics/Steroid,7,Down,Yes,"0,0051",not sig.,"Awan et al., 2015",Circulating biomarker candidate for HCC,http://www.ncbi.nlm.nih.gov/pubmed/26414287 ,
"Cytochrome P450, family 2, subfamily C, polypeptide 9",CYP2C9,1559,Steroid,Xenobiotics/Steroid,7,Down,Yes,not sig.,"0,0091","Tsunedomi et al., 2005",Downregulated in HCV-associated HCC and may be served as a marker of progression,https://www.ncbi.nlm.nih.gov/pubmed/16077914 ,
hydroxysteroid (11-beta) dehydrogenase 1,HSD11B1,3290,Steroid,Xenobiotics/Steroid,7,Down,Yes,"0,0307",not sig.,"Awan et al., 2015",Circulating biomarker candidate for HCC,http://www.ncbi.nlm.nih.gov/pubmed/26414287 ,
"cytochrome P450, family 2, subfamily C, polypeptide 8",CYP2C8,1558,Steroid,Xenobiotics/Steroid,8,Down,Yes,"0,0022",not sig.,"Ono et al., 1995",Low activity in HepG2,http://www.ncbi.nlm.nih.gov/pubmed/7663534 ,
"Cytochrome P450, family 3, subfamily A, polypeptide 4",CYP3A4,1576,Steroid,Xenobiotics/Steroid,7,Down,Yes,"0,001","0,0062","Huidobro et al., 2013",HCC expressing GNMT were of smaller size than tumors showing GNMT hypermethylation,http://www.ncbi.nlm.nih.gov/pubmed/23475283 ,
glucose-fructose oxidoreductase domain containing 2,GFOD2,81577,Sugar,Others,7,-,Yes,"0,0059","0,022",-,-,-,
glyoxylate reductase/hydroxypyruvate reductase,GRHPR,9380,Sugar,Others,7,Down,Yes,"< 0,0001","0,035","Pan et al., 2013",Prognostic marker in HCC after curative resection,https://www.ncbi.nlm.nih.gov/pubmed/?term=GRHPR+hcc,
"crystallin, lambda 1",CRYL1,51084,Sugar,Others,7,Down,Yes,"0,0045",< 0.0001,"Cheng et al., 2010",Downregulated in HCC and correlated with adverse patient prognosis.,http://www.ncbi.nlm.nih.gov/pubmed/19927314 ,
ketohexokinase (fructokinase),KHK,3795,Sugar,Others,8,Down,Yes,"Showed trend, P>0.1","0,00034","Li et al., 2016",Associated with poor prognosis for HCC,http://www.ncbi.nlm.nih.gov/pubmed/27088854 ,
sorbitol dehydrogenase,SORD,6652,Sugar,Others,7,Down,Yes,"0,0003",< 0.0001,-,-,-,
"amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III)",AGL,178,Sugar,Others,8,Down,Yes,"0,009",not sig.,-,-,-,
ribokinase,RBKS,64080,Sugar,Others,7,Down,Yes,"0,0351","0,0045",-,-,-,
"sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1",SULT2A1,6822,Sulfate,Others,6,Down,Yes,"0,0002","0,0023","Huang et al., 2005",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/15713538 ,
3'-phosphoadenosine 5'-phosphosulfate synthase 2,PAPSS2,9060,Sulfate,Others,7,Down,Yes,not sig.,not sig.,-,-,-,
"3-hydroxyanthranilate 3,4-dioxygenase",HAAO,23498,Tryptophan,Amino Acid*,7,Down,Yes,"0,0039","0,025",-,-,-,
tyrosine aminotransferase,TAT,6898,Tyrosine,Amino Acid*,8,-,Yes,"0,0503",not sig.,"Fu et al., 2010",Downregulated in HCC and contributes to its pathogenesis ,https://www.ncbi.nlm.nih.gov/pubmed/20209601,
"homogentisate 1,2-dioxygenase (homogentisate oxidase)",HGD,3081,Tyrosine,Amino Acid*,7,-,Yes,"0,0052","0,0011","Nakata et al., 1963",Downregulated in HCC bearing rats,http://www.ncbi.nlm.nih.gov/pubmed/13937495 ,
phenylalanine hydroxylase,PAH,5053,Tyrosine,Amino Acid*,7,Down,Yes,"0,0205","0,00052",-,Unclear,-,
fumarylacetoacetate hydrolase (fumarylacetoacetase),FAH,2184,Tyrosine,Amino Acid*,7,Down,Yes,"0,0444","0,015",-,-,-,
4-hydroxyphenylpyruvate dioxygenase,HPD,3242,Tyrosine,Amino Acid*,7,Down,Yes,"0,0052","0,014",-,-,-,
fumarylacetoacetate hydrolase domain containing 2A,FAHD2A,51011,Tyrosine,Amino Acid*,8,Down,Yes,"0,0015","0,038",-,none in any cancer,-,
argininosuccinate synthetase 1,ASS1,445,Urea,Urea,7,Down,Yes,"Showed trend, P>0.1","0,00021",Tan et al. 2014,Novel biomarker for stratifying HCC patients,https://www.ncbi.nlm.nih.gov/pubmed/?term=24946162,
"Arginase, liver",ARG1,383,Urea,Urea,7,Down,Yes,not sig.,"0,012","Salleng et al., 2015",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/26473343 ,
argininosuccinate lyase,ASL,435,Urea,Urea,6,Down,Yes,"0,0074","0,0035","Wu et al., 2013",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/23339388 ,
ornithine carbamoyltransferase,OTC,5009,Urea,Urea,7,Down,Yes,"0,0055","0,00092","Murayama et al., 2007",OCT/ALT is a potent indicator for the diagnosis and the prognosis of HCC,http://www.ncbi.nlm.nih.gov/pubmed/17570354 ,
"carbamoyl-phosphate synthetase 1, mitochondrial",CPS1,1373,Urea,Urea,7,Down,Yes,"0,011","0,00049","Liu et al., 2011",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/21281797 ,
"retinol saturase (all-trans-retinol 13,14-reductase)",RETSAT,54884,Vitamin A,Others,6,-,Yes,"0,0554","0,020",-,-,-,
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),LRAT,9227,Vitamin A,Others,6,-,Yes,not sig.,not sig.,"Revill et al., 2013",Reduced expression and hypermethylated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/?term=LRAT+hcc,
retinol dehydrogenase 5 (11-cis/9-cis),RDH5,5959,Vitamin A,Others,7,-,Yes,"Showed trend, P>0.1",not sig.,-,-,-,
retinol dehydrogenase 16 (all-trans),RDH16,8608,Vitamin A,Others,7,Down,Yes,"0,0089","0,0017","Udali et al., 2015", Repressed by DNA methylation in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25945129,
"cytochrome P450, family 26, subfamily A, polypeptide 1",CYP26A1,1592,Vitamin A,Xenobiotics/Steroid,8,-,Yes,not sig.,not sig.,"Kanki et al., 2013",Downregulated in HCC,https://www.ncbi.nlm.nih.gov/pubmed/23831118 ,
dicarbonyl/L-xylulose reductase,DCXR,51181,Xyulose,Others,7,Down,Yes,"0,002","0,0094",-,-,-,
mitochondrial pyruvate carrier 1,MPC1,51660,-,Glycolysis,8,-,No,-,-,"Schell et al., 2014",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/25458841,
6-pyruvoyltetrahydropterin synthase,PTS,5805,BH4,Others,8,-,No,-,-,-,-,-,
glycogenin 2,GYG2,8908,Carbohydrate Storage,Others,6,-,No,-,-,-,one in other cancers,-,
"vitamin K epoxide reductase complex, subunit 1",VKORC1,79001,Cofactor,Others,6,-,No,-,-,-,-,-,
dihydroxyacetone kinase 2 homolog (S. cerevisiae),DAK,26007,Cofactor,Others,7,Down,No,-,-,-,-,-,
"UDP glucuronosyltransferase 2 family, polypeptide B28",UGT2B28,54490,Detox,Detox,7,-,No,-,-,-,-,-,
"acyl-Coenzyme A oxidase 3, pristanoyl",ACOX3,8310,Fatty Acid,Fatty Acid,7,Up,No,-,-,-,-,-,
"ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)",ELOVL6,79071,Fatty Acid,Fatty Acid,6,-,No,-,-,"Kessler et al., 2014",Patients with NASH or NASH-related HCC have elevated expression of ELOVL6,http://www.ncbi.nlm.nih.gov/pubmed/24714086,
monoglyceride lipase,MGLL,11343,Fatty Acid,Fatty Acid,7,Down,No,-,-,"Rajasekaran et al., 2016","Undetected in human HCC cell lines; Forced overexpression in human HCC cells inhibited cell proliferation, and decrease in tumor growth in mouse xenograft ",www.ncbi.nlm.nih.gov/pubmed/26997225,
ornithine aminotransferase (gyrate atrophy),OAT,4942,Glutamate,Amino Acid*,6,-,No,-,-,-,Unclear,-,
glutathione S-transferase A3,GSTA3,2940,Glutathione,Glutathione,7,-,No,-,-,-,-,-,
"beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)",B3GAT1,27087,Glycan,Glycan,7,-,No,-,-,-,-,-,
"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1",B4GALT1,2683,Glycan,Glycan,7,-,No,-,-,"Michailidi et al., 2014",Is hypermethylated in HCC,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009191/,
"Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)",FUT6,2528,Glycan,Glycan,6,-,No,-,-,"Cheng et al., 2013",predominantly expressed in MDR cell lines;  mediates the multidrug resistance of HCC,http://www.ncbi.nlm.nih.gov/pubmed/24232099,
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4,CHST4,10164,Glycan Sulfate,Glycan,6,-,No,-,-,-,one in other cancers,http://onlinelibrary.wiley.com/doi/10.1002/hep.21330/abstract,
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,CHST7,56548,Glycan Sulfate,Glycan,6,-,No,-,-,-,-,-,
glycine dehydrogenase (decarboxylating),GLDC,2731,Glycine,Amino Acid*,6,Down,No,-,-,"Jung et al., 2013",Downregulated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/23515579,
"enolase 3 (beta, muscle)",ENO3,2027,Glycolysis,Glycolysis,7,Down,No,-,-,-,-,-,
histidine ammonia-lyase,HAL,3034,Histidine,Amino Acid*,7,Down,No,-,-,-,-,-,
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),PTGS2,5743,Hormone,Others,7,-,No,-,-,-,-,-,
hydroxyprostaglandin dehydrogenase 15-(NAD),HPGD,3248,Hormone,Others,8,Down,No,-,-,-,-,-,
"phosphoinositide-3-kinase, class 2, gamma polypeptide",PIK3C2G,5288,Inositol Phosphate,Others,7,-,No,-,-,-,-,-,
"Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",CFTR,1080,Ion Transport,Ion Transport,6,-,No,-,-,"Moribe et al., 2009",Aberrantly methylated in HCC,http://www.ncbi.nlm.nih.gov/pubmed/19384946,
"potassium voltage-gated channel, shaker-related subfamily, beta member 1",KCNAB1,7881,Ion Transport,Ion Transport,7,-,No,-,-,,-,-,
"potassium inwardly-rectifying channel, subfamily J, member 16",KCNJ16,3773,Ion Transport,Ion Transport,7,-,No,-,-,"Liu et al., 2014","""poor risk gene"" in HCC; potential target for diagnosis and predicting HCC progression",www.ncbi.nlm.nih.gov/pubmed/25243966,
"potassium large conductance calcium-activated channel, subfamily M, alpha member 1",KCNMA1,3778,Ion Transport,Ion Transport,8,-,No,-,-,-,-,-,
"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2",KCNN2,3781,Ion Transport,Ion Transport,8,-,No,-,-,-,-,-,
"solute carrier family 31, member 2",SLC31A2,1318,Ion Transport,Ion Transport,7,-,No,-,-,-,-,-,
"1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)",AGPAT2,10555,Membrane Lipid,Membrane Lipid,7,-,No,-,-,-,-,-,
glycerol kinase,GK,2710,Membrane Lipid,Membrane Lipid,6,-,No,-,-,-,-,-,
"phospholipase A2, group XVI",PLA2G16,11145,Membrane Lipid,Membrane Lipid,8,-,No,-,-,-,-,-,
"Phospholipase C, gamma 2 (phosphatidylinositol-specific)",PLCG2,5336,Membrane Lipid,Membrane Lipid,6,-,No,-,-,-,-,-,
plasticity-related gene 2,PRG2,79948,Membrane Lipid,Membrane Lipid,6,Up,No,-,-,-,-,-,
carbonic anhydrase II,CA2,760,Multipurpose,Multipurpose,7,Down,No,-,-,-,-,http://www.nature.com/aps/journal/v32/n7/full/aps201124a.html,
gamma-glutamyltransferase 5,GGT5,2687,Multipurpose,Multipurpose,7,Down,No,-,-,-,-,-,
"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)",GOT1,2805,Multipurpose,Multipurpose,7,Down,No,-,-,"Trivedi et al., 2016",serum aspartate transaminase predicts risk of HCC develoment from pimary biliary cirrhosis,http://www.ncbi.nlm.nih.gov/pubmed/25567117,
NAD kinase,NADK,65220,NAD,NAD,7,-,No,-,-,-,-,-,
nicotinamide N-methyltransferase,NNMT,4837,NAD,NAD,8,Down,No,-,-,"Kim et al., 2009","Downregulated in HCC, but high expression predicts shorter diseases free survival",www.ncbi.nlm.nih.gov/pubmed/19216803,
catechol-O-methyltransferase,COMT,1312,Neurotransmitter,Others,8,Down,No,-,-,"Yin et al., 2004",Associated with risk of HCC,http://www.ncbi.nlm.nih.gov/pubmed/15341023,
spermidine/spermine N1-acetyltransferase 1,SAT1,6303,Polyamine,Others,7,-,No,-,-,-,-,-,
coproporphyrinogen oxidase,CPOX,1371,Porphyrin,Others,6,-,No,-,-,-,-,-,
cytidine deaminase,CDA,978,Pyrimidine,Nucleotide,8,-,No,-,-,"Deng et al., 2014",Induced by inflammatory cytokines and/or chemokines; links inflammation and HCC; inhibit HBV replication and facilitate the generation of HCC-promoting HBV mutants ,http://www.ncbi.nlm.nih.gov/pubmed/24120759,
dihydropyrimidine dehydrogenase,DPYD,1806,Pyrimidine,Nucleotide,6,-,No,-,-,"Cai et al., 2015",Its siRNA-mediated inhibition increased the sensitivity of HCC cells to 5-FU in vitro,http://www.ncbi.nlm.nih.gov/pubmed/26457704,
ceruloplasmin (ferroxidase),CP,1356,Redox,Redox,6,-,No,-,-,Ferrin et al. 2015,Plasma protein biomarker of HCC,http://www.ncbi.nlm.nih.gov/pubmed/25789864,
phosphoglycerate dehydrogenase,PHGDH,26227,Serine,Serine,8,Down,No,-,-,"Wang et al., 2005",Polymorphism PHGDH(rs1801955) detected in HCC tissues ,www.ncbi.nlm.nih.gov/pubmed/16109524,
phosphoserine aminotransferase 1,PSAT1,29968,Serine,Serine,7,Down,No,-,-,-,-,-,
aquaporin 3 (Gill blood group),AQP3,360,Small Molecule Transport,S.M. Transport,7,-,No,-,-,"Chen et al., 2016","Upregulated in HCC; high expression correlated with tumour stage, lymphatic metastasis",http://www.ncbi.nlm.nih.gov/pubmed/27121567,
"NPC1 (Niemann-Pick disease, type C1, gene)-like 1",NPC1L1,29881,Small Molecule Transport,S.M. Transport,8,-,No,-,-,-,-,-,
"solute carrier family 16 (monocarboxylic acid transporters), member 10",SLC16A10,117247,Small Molecule Transport,S.M. Transport,8,-,No,-,-,-,-,-,
"solute carrier family 16 (monocarboxylic acid transporters), member 4",SLC16A4,9122,Small Molecule Transport,S.M. Transport,7,-,No,-,-,"Gao et al., 2015",High expression predicts poor survival in HCC,https://www.ncbi.nlm.nih.gov/pubmed/25446815,
"solute carrier family 17 (sodium phosphate), member 3",SLC17A3,10786,Small Molecule Transport,S.M. Transport,7,-,No,-,-,-,one in other cancers,-,
"solute carrier family 19 (sodium/hydrogen exchanger), member 3",SLC19A3,80704,Small Molecule Transport,S.M. Transport,7,-,No,-,-,-,-,-,
"solute carrier family 6 (neurotransmitter transporter), member 16",SLC6A16,28968,Small Molecule Transport,S.M. Transport,8,-,No,-,-,-,one in other cancers,-,
"solute carrier family 7 (cationic amino acid transporter, y+ system), member 8",SLC7A8,23428,Small Molecule Transport,S.M. Transport,8,-,No,-,-,-,-,-,
3-ketodihydrosphingosine reductase,KDSR,2531,Sphingosine,Others,7,-,No,-,-,-,none in other cancers,-,
"cytochrome P450, family 2, subfamily E, polypeptide 1",CYP2E1,1571,Steroid,Xenobiotics/Steroid,8,-,No,-,-,-,-,-,
hydroxysteroid (17-beta) dehydrogenase 2,HSD17B2,3294,Steroid,Xenobiotics/Steroid,7,-,No,-,-,"Zhang et al., 2014",Its polymorphism (rs8191246) is significantly associated with risk of HCC development,www.ncbi.nlm.nih.gov/pubmed/24563232,
"aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)",AKR1D1,6718,Steroid,Xenobiotics/Steroid,7,Down,No,-,-,-,-,-,
hydroxysteroid (17-beta) dehydrogenase 10,HSD17B10,3028,Steroid,Xenobiotics/Steroid,6,Down,No,-,-,-,-,-,
dermatan sulfate epimerase,DSE,29940,Sulfate,Others,6,-,No,-,-,-,-,-,
"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2",SULT1A2,6799,Sulfate,Others,6,-,No,-,-,-,-,-,
"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",SULT1A1,6817,Sulfate,Others,7,Down,No,-,-,"Want et al., 2009",Increased secondary to chronic hepatitis B virus infection,http://www.ncbi.nlm.nih.gov/pubmed/19906068,
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),KMO,8564,Tryptophan,Amino Acid*,7,-,No,-,-,"Jin et al., 2015",Upregulated in HCC tissues; novel prognostic biomarker; inhibition suppressed proliferation and migration,http://www.nature.com/articles/srep10466,
"tryptophan 2,3-dioxygenase",TDO2,6999,Tryptophan,Amino Acid*,7,-,No,-,-,-,-,-,
kynureninase (L-kynurenine hydrolase),KYNU,8942,Tryptophan,Amino Acid*,6,Down,No,-,-,-,-,-,
